Daniel Wechsler

Daniel Mark Wechsler currently works at Blue Star Innovation Partners, as CEO/Managing Partner, Southern Orthodontic Partners LLC, as Independent Director, and Shore Capital Partners LLC, as Operating Partner.
Dr. Wechsler also formerly worked at Smile Brands, Inc., as President & Chief Executive Officer from 2014 to 2016, Smile Brands Group, Inc., as Chief Executive Officer, Melinta Therapeutics, Inc., as President, Chief Executive Officer & Director from 2017 to 2018, NavaDerm Partners LLC, as Executive Chairman, Bausch & Lomb, Inc., as EVP & President-Global Pharmaceuticals from 2012 to 2013, Merck & Co., Inc., as Head-Business Development & US Strategy, Pfizer Inc., as Vice President, The Upjohn Co., as Principal, Bausch & Lomb Holdings, Inc., as Executive VP & President-Global Pharmaceuticals, Welsh, Carson, Anderson & Stowe, as Operating Partner, Schering-Plough Ltd., as VP-Global Business Operations & Selling Excellence in 2009, and Bausch Health Cos., Inc., as Executive Vice President.
Dr. Wechsler received his graduate degree from Rochester Christian University and undergraduate degree from State University of New York College at Brockport.